Koyfin Home > Directory > Health Care > Akebia Therapeutics > Diluted Shares Outstanding

Akebia Therapeutics Diluted Shares Outstanding Chart (AKBA)

Akebia Therapeutics annual/quarterly Diluted Shares Outstanding from 2012 to 2020.
  • Akebia Therapeutics Diluted Shares Outstanding for the quarter ending June 06, 2020 was $137m a 13.18% increase of 18m year over year
  • Akebia Therapeutics Diluted Shares Outstanding for the last 12 months ending June 06, 2020 was $126m a 15.85% increase of 20m year over year
  • Akebia Therapeutics Annual Diluted Shares Outstanding for 2019 was $118m a 50.98% increase of 60m from 2018
  • Akebia Therapeutics Annual Diluted Shares Outstanding for 2018 was $58m a 25.05% increase of 15m from 2017
  • Akebia Therapeutics Annual Diluted Shares Outstanding for 2017 was $44m a 13.30% increase of 6m from 2016
Other Per Share Metrics:
  • Akebia Therapeutics Diluted EPS Excl. Extra Items for the quarter ending December 12, 2018 was $-1m a 44.23% decrease of 0m year over year
  • Akebia Therapeutics Diluted EPS Incl. Extra Items for the quarter ending December 12, 2018 was $-1m a 44.23% decrease of 0m year over year
View Chart On Koyfin

Quarterly AKBA Diluted Shares Outstanding Data

06/2020$137m
03/2020$128m
12/2019$119m
09/2019$119m
06/2019$118m
03/2019$117m
12/2018$70m
09/2018$57m
06/2018$57m
03/2018$49m

Annual AKBA Diluted Shares Outstanding Data

2019$118m
2018$58m
2017$44m
2016$38m
2015$26m
2014$15m
2013$1m
2012$0m
2011$0m